Who is sponsoring NCT04960475?

NCT04960475 is sponsored by Peking University Third Hospital.

What drugs are being tested in NCT04960475?

Interventions in NCT04960475: Hospital Anxious and Depression(HADS), Fear-Avoidance Belief Questionnaire (FABQ), The MOS 36-Item Short From Health Survey (SF-36).

What condition does NCT04960475 study?

NCT04960475 studies Chronic Ankle Sprain.

Is NCT04960475 still recruiting?

NCT04960475 is currently status unknown. Last updated 24 November 2021.

Last reviewed 2021-11-24 · How we verify

NCT04960475

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of Negative Emotion, Fear-Avoidance Belief and Quality of Life in Patients With Ankle Sprain

Status unknown Last updated 24 November 2021

What this trial tests

trial testing Hospital Anxious and Depression(HADS) in Chronic Ankle Sprain in 140 participants. Status unknown.

Timeline

1 January 2021

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Peking University Third Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	140
Start date	1 January 2021
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across China

Drugs / interventions tested

Hospital Anxious and Depression(HADS)
Fear-Avoidance Belief Questionnaire (FABQ)
The MOS 36-Item Short From Health Survey (SF-36)

Conditions studied

Chronic Ankle Sprain — all drugs for Chronic Ankle Sprain →

Sponsor

Peking University Third Hospital

Who can join

Adults 18 to 80, any sex, with Chronic Ankle Sprain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study intends to investigate the negative emotions, fear-avoidance beliefs, and quality of life in patients with chronic ankle sprains to explore the relationship between negative emotions such as anxiety and depression, fear-avoidance beliefs, and their impact on quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04960475 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 24 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04960475.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing